Macroaxis Stories

Will Dolby Laboratories (USA Stocks:DLB) shadow Skechers USA price jump?

November 19, 2024  By
Dolby Laboratories' robust market capitalization of 6.8B and a strong institutional ownership of 94.13% suggest a solid foundation, making it a potentially attractive buy for investors seeking stability. However, with a modest five-year return of just 1.09%, those looking for rapid growth might want to consider other options.

Main Takeaways

By examining key indicators for Dolby Laboratories and Skechers, you can assess how market fluctuations impact their stock prices and determine if combining them in a portfolio might reduce overall risk. Pair trading strategies could be employed by taking a long position in Skechers and a short position in Dolby Laboratories. For more details, explore our [pair correlation module](#) on their relationship. Now, let's delve into asset analysis. The asset utilization ratio measures how much revenue a company generates per dollar of assets. Dolby Laboratories has a ratio of 33.87%, indicating it earns $0.34 for every dollar of assets. A rising asset utilization ratio suggests that Dolby is becoming more efficient in using its assets for daily operations.
Published over two weeks ago
View all stories for Eaton Vance | View All Stories

Reviewed by Michael Smolkin

Success often leaves clues, and investors are keen to decipher whether Dolby Laboratories can replicate the remarkable ascent of Skechers USA. With a robust current ratio of 5.27X, Dolby's financial health appears solid, hinting at its ability to meet short-term obligations with ease. As a key player in the Specialty Business Services industry, Dolby has carved out a niche with its innovative audio technologies. However, the question remains whether this stability and specialization can propel its stock to new heights akin to Skechers' recent performance. Many millennials are enthusiastic about the electronic equipment, instruments, and components sector. With this in mind, we're taking a closer look at Dolby Laboratories and Skechers USA as potential short-term investment opportunities. We'll examine the competitive strengths of both companies to see what sets them apart.

Instrument Allocation

The asset allocation of funds such as Eaton Vance usually varies among a different mix of asset classes. Balanced mutual funds invest not only in bonds, which focus primarily on income, and stocks, which aim for investment growth, but also keep some reserve in cash or even exotic instruments. Below we show the current asset allocation of Eaton Vance Global
Details

Another Deeper Perspective

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Lets now take a look at Dolby Laboratories revenue. Based on the latest financial disclosure, Dolby Laboratories reported 1.01 B of revenue.
This is 75.24% lower than that of the Electronic Equipment, Instruments & Components sector and 88.12% lower than that of the Information Technology industry. The revenue for all United States stocks is 89.3% higher than that of the firm. As for Skechers USA we see revenue of 8 B, which is 5.82% lower than that of the Information Technology
Sector
4.1 B
SKX
B
DLB1.01 Billion7.71
Sector4.08 Billion31.15
SKX8 Billion61.14
Fortune favors the bold, and investors in Dolby Laboratories might need a touch of courage as they ponder the stock's potential trajectory. While Skechers USA recently dazzled with a significant price surge, Dolby’s current financial metrics present a more tempered outlook. With an operating margin of just 0.14% and a five-year return of 1.09%, the company hasn't demonstrated the explosive growth seen in some other sectors. However, Dolby's robust current ratio of 5.27x indicates a strong liquidity position, which could provide a cushion for future strategic moves. As the market continues to evolve, Dolby's ability to capitalize on its strengths and navigate challenges will determine if it can echo Skechers' recent success..

Dolby Laboratories has a good chance to finish above $73 in 2 months

Dolby Laboratories is showing potential, with a semi-deviation of 1.09, indicating a relatively stable performance compared to its peers. This measure of downside risk suggests that the stock's price movements have been moderate, offering a more predictable investment environment. With this stability, Dolby has a good chance of exceeding the $73 mark within the next two months, making it appealing for investors seeking growth with balanced risk. Dolby Laboratories also exhibits low volatility, with a skewness of 0.02 and kurtosis of -0.16. Understanding these volatility trends can help investors time their market moves. During bear markets, increased volatility can affect Dolby's stock price, prompting investors to adjust their portfolios by diversifying as prices drop.

Our Takeaway on Dolby Laboratories Investment

When is the right time to buy or sell Dolby Laboratories? Buying stocks such as Dolby Laboratories isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily basis.
While some investors may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Dolby Laboratories.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Eaton Vance Global. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com